NutriBand Inc. (NTRB)

Nutriband, Inc. engages in the development of a portfolio of transdermal pharmaceutical products. It operates through the Pocono Pharmaceuticals and 4P Therapeutics segments. The Pocono Pharmaceuticals segment relates to a coated products manufacturing entity. The 4P Therapeutics segment performs contract research and development services. The company was founded by Gareth R. Sheridan and Serguei Melnik in 2012 and is headquartered in Orlando, FL.

Address

121 S. ORANGE AVE.

ORLANDO, FL 32801

Founded

2012

Number of Employees

-

Website

http://www.nutriband.com

Buyback

Buyback Data	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	Average
$ Amount Purchased ($ in 000s)	-	-	-	-	-	-	-	-	$89	-	-	$89
Average Price	-	-	-	-	-	-	-	-	$3.32	-	-	$3.32
# Shares Purchased	-	-	-	-	-	-	-	-	26,836	-	-	26,836

Buyback Performance	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	Average
Total Return to Date	-	-	-	-	-	-	-	-	20.4%	-	-	20.4%
S&P 500 Return to Date	-	-	-	-	-	-	-	-	37.3%	-	-	37.3%
Excess Total Return	-	-	-	-	-	-	-	-	-16.9%	-	-	-16.9%
Quartile Rank
Percentile Rank	-	-	-	-	-	-	-	-	63%	-	-	55%

Buyback returns calculated using weighted average buyback price over the last 10 years and comparing to current day stock price value. S&P 500 used as benchmark for excess return.

Insider Transactions

Filters

Keyboard Shortcuts: Show (a) | Close (Esc)